Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 28;24(5):111.
doi: 10.1208/s12249-023-02567-y.

Emerging Advances in Nanocarriers Approaches in the Effective Therapy of Pain Related Disorders: Recent Evidence and Futuristic Needs

Nishtha Chaurawal  1 , Mohak Kataria  2 , Muniramiah Vinod Kumar  3 , Narayan Prasad Mishra  4 , Vijay G Goni  2 , Kaisar Raza  5
Affiliations
Review

Emerging Advances in Nanocarriers Approaches in the Effective Therapy of Pain Related Disorders: Recent Evidence and Futuristic Needs

Nishtha Chaurawal et al. AAPS PharmSciTech. .

Abstract

Pain disorders are the primary cause of disability nowadays. These disorders, such as rheumatoid arthritis (RA) and osteoarthritis (OA), cause loss of function, joint pain and inflammation and deteriorate the quality of life. The treatment of these inflammatory diseases includes anti-inflammatory drugs administered via intra-articular, topical or oral routes, physical rehabilitation or surgery. Owing to the various side effects these drugs could offer, the novel approaches and nanomaterials have shown potential to manage inflammatory diseases, prolonged half-life of anti-inflammatory drugs, reduced systemic toxicity, provide specific targeting, and refined their bioavailability. This review discusses in brief about the pain pathophysiology and its types. The review summarizes the conventional therapies used to treat pain disorders and the need for novel strategies to overcome the adverse effects of conventional therapies. The review describes the recent advancements in nanotherapeutics for inflammatory diseases using several lipids, polymers and other materials and their excellent efficiency in improving the treatment over conventional therapies. The results of the nanotherapeutic studies inferred that the necessity to use nanocarriers is due to their controlled release, targeting drug delivery to inflamed tissues, low toxicity and biocompatibility. Therefore, it is possible to assert that nanotechnology will emerge as a great tool for advancing the treatment of pain disorders in the near future.

Keywords: musculoskeletal disorders; nanostrategies; osteoarthritis; pain; pain mechanism; rheumatoid arthritis.

PubMed Disclaimer

References

    1. Babaie S, Taghvimi A, Hong J-H, Hamishehkar H, An S, Kim KH. Recent advances in pain management based on nanoparticle technologies. J Nanobiotechnol Internet [Internet] BioMed Central. 2022;20:1–25. https://doi.org/10.1186/s12951-022-01473-y . - DOI
    1. Keefe FJ, Kashikar-Zuck S, Opiteck J, Hage E, Dalrymple L, Blumenthal JA. Pain in arthritis and musculoskeletal disorders: the role of coping skills training and exercise interventions. J Orthop Sports Phys Ther. 1996;24:279–90. - DOI - PubMed
    1. National Statistics Text Descriptions | Data and Statistics | Arthritis | CDC [Internet]. [cited 2022 Jul 8]. Available from: https://www.cdc.gov/arthritis/data_statistics/national-statistics-text-v... . Accessed 08/07/2022.
    1. National Statistics | CDC [Internet]. [cited 2022 Jul 8]. Available from: https://www.cdc.gov/arthritis/data_statistics/national-statistics.html . Accessed 08/07/2022.
    1. Arthritis statistics 2022: What percent of the population has arthritis? [Internet]. [cited 2022 Jul 8]. Available from: https://www.singlecare.com/blog/news/arthritis-statistics/ . Accessed 09/07/2022.

MeSH terms

Substances